Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 33

1.

Pseudotumor cerebri syndrome in childhood: incidence, clinical profile and risk factors in a national prospective population-based cohort study.

Matthews YY, Dean F, Lim MJ, Mclachlan K, Rigby AS, Solanki GA, White CP, Whitehouse WP, Kennedy CR.

Arch Dis Child. 2017 Aug;102(8):715-721. doi: 10.1136/archdischild-2016-312238. Epub 2017 Mar 29.

PMID:
28356250
2.

Intraductal tubulopapillary neoplasm of pancreas with associated invasive carcinoma, lymph node, rectal and hepatic metastases.

Matthews Y, McKenzie C, Byrne C, Kench JG.

Pathology. 2015 Feb;47(2):169-71. doi: 10.1097/PAT.0000000000000228. No abstract available.

PMID:
25551309
3.

Microchimerism in the transfused obstetric population.

Bloch EM, Busch MP, Lee TH, Montalvo L, Matthews Y, Bird A, Bruhn R, Stefan V.

Vox Sang. 2014 Nov;107(4):428-30. doi: 10.1111/vox.12177. Epub 2014 Jul 16.

PMID:
25040346
4.

Response regarding CLIPPERS.

Kossard S, Smith A, Matthews Y, Turner J, Buckland ME, Parratt J.

J Cutan Pathol. 2014 Sep;41(9):761. doi: 10.1111/cup.12360. Epub 2014 Jun 30. No abstract available.

PMID:
24979349
5.

Neurotropic T-cell lymphocytosis: a cutaneous expression of CLIPPERS.

Smith A, Matthews Y, Kossard S, Turner J, Buckland ME, Parratt J.

J Cutan Pathol. 2014 Aug;41(8):657-62. doi: 10.1111/cup.12344. Epub 2014 May 21.

PMID:
24641246
6.

An action spectrum for ultraviolet radiation-induced immunosuppression in humans.

Damian DL, Matthews YJ, Phan TA, Halliday GM.

Br J Dermatol. 2011 Mar;164(3):657-9. doi: 10.1111/j.1365-2133.2010.10161.x. Epub 2011 Feb 17.

PMID:
21375518
7.

Wavelength dependency for UVA-induced suppression of recall immunity in humans.

Matthews YJ, Halliday GM, Phan TA, Damian DL.

J Dermatol Sci. 2010 Sep;59(3):192-7. doi: 10.1016/j.jdermsci.2010.07.005. Epub 2010 Aug 9.

PMID:
20691571
8.

Topical riboflavin attenuates ultraviolet B- and ultraviolet A-induced immunosuppression in humans.

Damian DL, Matthews YJ, Halliday GM.

Photodermatol Photoimmunol Photomed. 2010 Apr;26(2):66-9. doi: 10.1111/j.1600-0781.2010.00486.x.

PMID:
20415736
9.

A UVB wavelength dependency for local suppression of recall immunity in humans demonstrates a peak at 300 nm.

Matthews YJ, Halliday GM, Phan TA, Damian DL.

J Invest Dermatol. 2010 Jun;130(6):1680-4. doi: 10.1038/jid.2010.27. Epub 2010 Feb 25.

10.

Topical photodynamic therapy is immunosuppressive in humans.

Matthews YJ, Damian DL.

Br J Dermatol. 2010 Mar;162(3):637-41. doi: 10.1111/j.1365-2133.2009.09562.x. Epub 2009 Oct 26.

PMID:
19863500
11.

CD4+/CD8+ T cell ratio for diagnosis of HIV-1 infection in infants: Women and Infants Transmission Study.

Pahwa S, Read JS, Yin W, Matthews Y, Shearer W, Diaz C, Rich K, Mendez H, Thompson B; Women and Infants Transmission Study.

Pediatrics. 2008 Aug;122(2):331-9. doi: 10.1542/peds.2007-2308.

12.

Drugs used in childhood idiopathic or benign intracranial hypertension.

Matthews YY.

Arch Dis Child Educ Pract Ed. 2008 Feb;93(1):19-25. doi: 10.1136/adc.2006.107326. Review. No abstract available.

PMID:
18208981
13.

Gender differences in lymphocyte populations, plasma HIV RNA levels, and disease progression in a cohort of children born to women infected with HIV.

Foca M, Moye J, Chu C, Matthews Y, Rich K, Handelsman E, Luzuriaga K, Paul M, Diaz C; Women and Infants Transmission Study.

Pediatrics. 2006 Jul;118(1):146-55.

PMID:
16818560
14.

Biopsy features are associated with primary symptoms in interstitial cystitis: results from the interstitial cystitis database study.

Tomaszewski JE, Landis JR, Russack V, Williams TM, Wang LP, Hardy C, Brensinger C, Matthews YL, Abele ST, Kusek JW, Nyberg LM; Interstitial Cystitis Database Study Group.

Urology. 2001 Jun;57(6 Suppl 1):67-81.

PMID:
11378053
15.

Literacy assessment in a cardiovascular nutrition education setting.

TenHave TR, Van Horn B, Kumanyika S, Askov E, Matthews Y, Adams-Campbell LL.

Patient Educ Couns. 1997 Jun;31(2):139-50.

PMID:
9216355
16.

CT percutaneous biopsy guns: comparison of end-cut and side-notch devices in cadaveric specimens.

Hopper KD, Abendroth CS, Sturtz KW, Matthews YL, Hartzel JS, Potok PS.

AJR Am J Roentgenol. 1995 Jan;164(1):195-9.

PMID:
7998539
17.

Transforming growth-factor-alpha and factor-beta(1) levels in plasma and effusions from patients with cancer or hematologic malignancies.

Witters L, Almondhiry H, Matthews Y, Walker R, Langton B, Dasch J, Lipton A.

Int J Oncol. 1994 Apr;4(4):943-50.

PMID:
21567004
18.

The effect of informed consent on the level of anxiety in patients given i.v. contrast material.

Hopper KD, Houts PS, TenHave TR, Matthews YL, Colon E, Haseman DB, Hartzel J.

AJR Am J Roentgenol. 1994 Mar;162(3):531-5.

PMID:
8109491
19.

Risks associated with the use of IV contrast material: analysis of patients' awareness.

Neptune SM, Hopper KD, Matthews YL.

AJR Am J Roentgenol. 1994 Feb;162(2):451-4.

PMID:
8310946
20.

Secular trends in blood pressure among adult blacks and whites aged 18-34 years in two body mass index strata, United States, 1960-1980.

Kumanyika SK, Landis JR, Matthews YL, Weaver SL, Harlan LC, Harlan WR.

Am J Epidemiol. 1994 Jan 15;139(2):141-54.

PMID:
8296781
21.

Adjustable-depth biopsy device: comparison with a single-depth biopsy gun in cadaveric organs.

Hopper KD, Abendroth CS, Sturtz KW, Matthews YL.

AJR Am J Roentgenol. 1993 Dec;161(6):1307-8. No abstract available.

PMID:
8249748
22.

Blinded comparison of biopsy needles and automated devices in vitro: 2. Biopsy of medical renal disease.

Hopper KD, Abendroth CS, Sturtz KW, Matthews YL, Shirk SJ, Stevens LA.

AJR Am J Roentgenol. 1993 Dec;161(6):1299-301.

PMID:
8249746
23.

Blinded comparison of biopsy needles and automated devices in vitro: 1. Biopsy of diffuse hepatic disease.

Hopper KD, Abendroth CS, Sturtz KW, Matthews YL, Shirk SJ, Stevens LA.

AJR Am J Roentgenol. 1993 Dec;161(6):1293-7.

PMID:
8249745
24.

Automated biopsy devices: a blinded evaluation.

Hopper KD, Abendroth CS, Sturtz KW, Matthews YL, Stevens LA, Shirk SJ.

Radiology. 1993 Jun;187(3):653-60.

PMID:
8497611
25.

Patient choice and nonionic contrast media.

Hopper KD, Matthews YL.

Invest Radiol. 1993 Apr;28(4):303-7.

PMID:
8478170
26.

Interleukin-2 and interferon-alpha-2a outpatient therapy for metastatic renal cell carcinoma.

Lipton A, Harvey H, Givant E, Hopper K, Lawler J, Matthews Y, Hirsh M, Zeffren J.

J Immunother Emphasis Tumor Immunol. 1993 Feb;13(2):122-9.

PMID:
8318497
27.

Fine-needle aspiration biopsy for cytopathologic analysis: utility of syringe handles, automated guns, and the nonsuction method.

Hopper KD, Abendroth CS, Sturtz KW, Matthews YL, Shirk SJ.

Radiology. 1992 Dec;185(3):819-24.

PMID:
1438769
28.

Prognostic value of breast cancer aromatase.

Lipton A, Santen RJ, Santner SJ, Harvey HA, Sanders SI, Matthews YL.

Cancer. 1992 Oct 1;70(7):1951-5.

PMID:
1525771
29.

Ventricular assist devices for postcardiotomy cardiogenic shock. A combined registry experience.

Pae WE Jr, Miller CA, Matthews Y, Pierce WS.

J Thorac Cardiovasc Surg. 1992 Sep;104(3):541-52; discussion 552-3.

PMID:
1513144
30.

Use of informed consent for ionic and nonionic contrast media.

Lambe HA, Hopper KD, Matthews YL.

Radiology. 1992 Jul;184(1):145-8.

PMID:
1609071
31.

Patients' attitudes toward informed consent for intravenous contrast media.

Hopper KD, Houts PS, McCauslin MA, Matthews YL, Sefczek RJ.

Invest Radiol. 1992 May;27(5):362-6.

PMID:
1582819
32.

Current usage of nonionic contrast.

Hopper KD, Lambe H, Matthews YL.

Urol Radiol. 1992;14(3):218-20.

PMID:
1290217
33.

A quick, simple and reliable histochemical method for ATPase in human muscle preparations.

Round JM, Matthews Y, Jones DA.

Histochem J. 1980 Nov;12(6):707-10. No abstract available.

PMID:
6160131

Supplemental Content

Loading ...
Support Center